IBIO Insider Trading Activity and SEC Form 4 Filings
IBIO insider trading summary
Over the past 12 months, insiders at iBio, Inc. (IBIO) reported 2 open-market purchases worth $75K by 2 insiders and no sales on SEC Form 4. Net insider buying was $75K.
Latest IBIO insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Mar 19, 2026 | Felipe Duran | Chief Financial Officer | Buy | $50K (24,835 @ $2.02) |
| Mar 19, 2026 | Martin Brenner | See Remarks | Buy | $25K (12,336 @ $2.02) |
| Jan 10, 2025 | Felipe Duran | Chief Financial Officer | Buy | $25K (9,191 @ $2.72) |
| Jan 10, 2025 | Antonio Bernardino Guimaraes Parada | Director | Buy | $500K (183,823 @ $2.72) |
| Jan 10, 2025 | Gary Sender | Director | Buy | $25K (9,191 @ $2.72) |
| Jan 10, 2025 | Marc Banjak | Chief Legal Officer | Buy | $25K (9,191 @ $2.72) |
| Jan 10, 2025 | David Arkowitz | Director | Buy | $50K (18,382 @ $2.72) |
| Jan 10, 2025 | Martin Brenner | See Remarks | Buy | $25K (9,191 @ $2.72) |
| Jan 10, 2025 | William D Clark | Director | Buy | $5K (1,838 @ $2.72) |
| Nov 1, 2023 | Martin Brenner | See Remarks | Sell | $1K (4,881 @ $0.27) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.